News

cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms

Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms

TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

The Winner of the Venture Challenge Summer 2020 is PacingCure!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Summer 2020 is PacingCure!

UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

Venture Challenge alumni TargED closes seed investment

TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug  TargED Biopharmaceuticals, a biotech spin-
Venture Challenge alumni TargED closes seed investment

Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020

Toxys is very proud to announce that they been selected as one of the FD Gazelles of 2020.
Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020

GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook

“With its commitment to enhancing treatment options for the most urgent medical needs, GlycoCheck and Microvascular Health Solutions is moving the needle in microvascular health and ensuring quality care for all,” reported MedTech Outlook 
GlycoCheck has been named one of the Top 10 Diabetes Care Solution Providers in 2020 by MedTech Outlook

UNIIQ investeert 250.000 euro in biotech-startup en Venture Challenge alumnus BIOND Solutions

Spin-off van de TU Delft BIOND Solutions (Bi/ond) ontwikkelde een microchip om menselijke cellen en weefsels op te kweken en te voorzien van zuurstof en voedingsstoffen.
UNIIQ investeert 250.000 euro in biotech-startup en Venture Challenge alumnus BIOND Solutions

Venture Challenge alumnus Sirius Medical proudly announces the first clinical results and global commercial implants of its Sirius Pintuition soft-tissue localization system

Sirius Medical is proud to announce the first clinical results and global commercial implants of the Sirius Pintuition system. The first clinical safety and performance study shows that Sirius Pintuition System is safe and performs as intended for breast cance
Venture Challenge alumnus Sirius Medical proudly announces the first clinical results and global commercial implants of its  Sirius Pintuition soft-tissue localization system